Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks

Page 5 of 10

6. Artivion, Inc. (NYSE:AORT)

Number of Hedge Fund Holders: 17

Perceptive Advisors’ Stake: $6.7 million

Artivion, Inc. (NYSE:AORT) is a medical device company specializing in cryogenically preserved human tissues and innovative surgical solutions, notably heart valves and surgical adhesives. There are multiple factors that make Artivion a golden opportunity to invest in. Firstly, in the third quarter of 2024, the company reported revenue of $95.8 million as compared to $87.9 million in the third quarter of 2023, showing an increase of 9% on a GAAP basis and 10% on a non-GAAP constant currency basis. Secondly, the company has invested an additional $25 million in Endospan to support the Food and Drug Administration approval path for the NEXUS Stent Graft System. It is designed for the aortic arch disease and specializes in controlling 2-stage procedures. Moreover, the company has also received regulatory approval to commercialize BioGlue in China, a significant market with substantial growth potential.

Page 5 of 10